Families and healthcare providers deserve access to the powerful and insightful knowledge held within our DNA when making difficult medical decisions. At PerkinElmer Genomics, we strive to make this a reality; faster, more affordable and at a higher quality than any other means available. By shining a light into the complex, uncharted landscape of genomics, we are shaping its future and the impact it will have on our lives.
PerkinElmer Genomics is a state-of-the-art biochemical and molecular genetics laboratory that provides newborn screening and genomic testing services around the world. With over 7.5 million newborns screened since 1994, our laboratory pairs decades of newborn screening experience with a leading-edge clinical genomics program to offer one of the world’s most comprehensive programs for detecting clinically significant genomic changes.
Our staff includes experts from across the clinical diagnostic arena, including world-renown geneticist Dr. Madhuri Hegde, a staff of board-certified geneticists and genetic counselors, laboratory scientists certified by the American Board of Bioanalysis, and experts in tandem mass spectrometry. The laboratory is registered with the College of American Pathologists (CAP), the Centers for Medicare and Medicaid Services, the Clinical Laboratory Improvement Amendments (CLIA), the Joint Commission of Healthcare Organizations (JCHO), and the Commission for Office Laboratory Accreditation (COLA). PerkinElmer Genomics also participates in the Newborn Screening Quality Assurance Program administered by the Centers for Disease Control and Prevention.